Recombinant Full Length Danio Rerio Apelin Receptor A(Aplnra) Protein, His-Tagged
Cat.No. : | RFL2760DF |
Product Overview : | Recombinant Full Length Danio rerio Apelin receptor A(aplnra) Protein (Q7SZP9) (1-362aa), fused to N-terminal His tag, was expressed in E. coli. |
- Specification
- Gene Information
- Related Products
- Download
Source : | E.coli expression system |
Species : | Danio rerio (Zebrafish) (Brachydanio rerio) |
Tag : | His |
Form : | Lyophilized powder |
Protein Length : | Full Length (1-362) |
AA Sequence : | MEPTSEYTETYDYYDTGYNDSGCDY SEWEPSYSLIPVLYMLIFILGLSGN GVVIFTVWRA KSKRRAADVYIGNLALADLTFVITL PLWAVYTALGYHWPFGVALCKISSY VVLVNMYASV FCLTCLSFDRYLAIVHSLSSGRLRS RATMLASLGAIWFLSCLLAVPTLLF RTTVDDTGSN RTTCAMDFSLVTLNQDHESLWIAGL SLSSSALGFLLPFLAMTVCYCFIGC TVTRHFSHLR KEDQKKRRLLKIITTLVVVFAFCWT PFHVLKSMDALSYLDLAPNSCGFLH FLLLAHPYAT CLAYVNSCLNPFLYAFFDLRFRSQC LCLLNLKKAMHGHMSSMSSTLSAQT QKSEVQSLAT KV |
Purity : | Greater than 90% as determined by SDS-PAGE. |
Notes : | Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week. |
Storage : | Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles. |
Storage Buffer : | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
Reconstitution : | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference. |
Gene Name : | aplnra |
Synonyms : | aplnra; agtrl1; agtrl1a; Apelin receptor A; Angiotensin II receptor-like 1a; Angiotensin receptor-like 1a; G-protein coupled receptor APJ A |
UniProt ID : | Q7SZP9 |
Gene Name : | aplnra |
Synonyms : | aplnra; agtrl1; agtrl1a; Apelin receptor A; Angiotensin II receptor-like 1a; Angiotensin receptor-like 1a; G-protein coupled receptor APJ A |
UniProt ID : | Q7SZP9 |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (20)
Ask a questionAPLNRA s need to be refrigerated and stored within a specified temperature range to maintain their activity and stability.
When using APLNRA , attention should be paid to its refrigeration, appropriate use and medical advice. ️
The preparation process of APLNRA includes the steps of expression, purification and examination.
APLNRA is suitable for patients with cardiovascular disease, especially those with heart failure.
Compared with traditional drugs, APLNRA has better efficacy, but further clinical validation is still needed.
APLNRA research is progressing rapidly and is currently in preclinical and clinical trials.
APLNRA needs to pass rigorous drug clinical trials and safety evaluation before it can be marketed.
Based on preliminary study results, the combination of APLNRA with other drugs is safe.
APLNRA can be applied in the treatment of cardiovascular diseases, and is expected to become a new generation of therapeutic drugs.
There is currently a lack of studies on APLNRA in children, so it is not recommended to give it to children.
Yes, APLNRA s need to be refrigerated at low temperatures to maintain their stability.
As the APLNRA is still under development, the price cannot be determined at this time.
There is currently insufficient evidence that APLNRA can be used to prevent cardiovascular disease.
APLNRA can reduce blood pressure and is conducive to the improvement of cardiovascular function.
APLNRA s bind to AplnRa receptors, which in turn regulate vasodilation and cardiac function.
To date, few side effects of APLNRA s have been reported, so it should be relatively safe.
There are no definitive conclusions, but preliminary findings suggest that long-term use of APLNRA s may be feasible.
Yes, APLNRA has been shown to have therapeutic potential for heart failure.
Clinical trials of APLNRA s are progressing well, but further observation and validation are needed.
APLNRA can be used in the scientific research field to study the pathogenesis of cardiovascular diseases and the development of new drugs.
Customer Reviews (5)
Write a reviewQuality of APLNRA was very high, which made my experiments smoother and more accurate.
Production process of APLNRA focuses on the recycling of resources and minimizes the disposal of waste, which is very much in line with the standards of green production.
The anti-interference ability of APLNRA in Western blot is very strong, which can effectively resist the influence of endogenous interfering factors and ensure the accuracy of experimental results.
Regardless of the experimental conditions, the stability of APLNRA remained consistent, which brought great convenience to our experiments.
The results of multiple tests are consistent, and the effect is very good.
Ask a Question for All aplnra Products
Required fields are marked with *
My Review for All aplnra Products
Required fields are marked with *
Inquiry Basket